top of page
Tirzepatide (Zepbound®): Its Effects on Sleep Apnea in the Surmount-OSA Phase 3 Trial
Key Takeaways ● Tirzepatide significantly reduced obstructive sleep apnea (OSA) severity in the Surmount-OSA clinical trial ● ...
Sleep Apnea and Obesity: Risks, Policy, and Tirzepatide (Zepbound®)
As part of the Alliance of Sleep Apnea Partners' Breathing Room series, UC San Diego sleep medicine researcher Dr. Chris Schmickl and Dr. Tracy Zvenyach, a registered nurse and Ph.D. who is also a policy expert, share valuable insights about the sleep apnea - obesity connection, as well as treatment approaches, including the medication tirzepatide (Zepbound).
bottom of page